taxonomy (1)
protein (1)
source (1)
structure (0)
composition (28)
disease (1)
reference (1)
site (4)
peptide (4)
- Homo sapiens (Human)
Taxonomy
- Mammary Gland (UBERON_0001911)
Source
Reported structure
- Hex:3 HexNAc:4 NeuAc:2 (avg mass : 1899.7383 )
- Hex:4 HexNAc:3 dHex:3 (avg mass : 1714.5989 )
- Hex:4 HexNAc:4 dHex:2 NeuAc:1 (avg mass : 2062.9088 )
- Hex:4 HexNAc:6 (avg mass : 1885.7549 )
- Hex:5 HexNAc:2 (avg mass : 1235.1173 )
- Hex:5 HexNAc:2 dHex:1 (avg mass : 1381.2603 )
- Hex:5 HexNAc:3 (avg mass : 1438.3123 )
- Hex:5 HexNAc:3 dHex:1 (avg mass : 1584.4553 )
- Hex:5 HexNAc:3 dHex:2 (avg mass : 1730.5983 )
- Hex:5 HexNAc:3 dHex:3 (avg mass : 1876.7413 )
- Hex:5 HexNAc:4 NeuAc:2 (avg mass : 2224.0231 )
- Hex:5 HexNAc:4 dHex:1 (avg mass : 1787.6503 )
- Hex:5 HexNAc:4 dHex:2 NeuAc:1 (avg mass : 2225.0512 )
- Hex:5 HexNAc:4 dHex:3 (avg mass : 2079.9363 )
- Hex:5 HexNAc:4 dHex:4 (avg mass : 2226.0793 )
- Hex:6 HexNAc:2 (avg mass : 1397.2597 )
- Hex:6 HexNAc:3 (avg mass : 1600.4547 )
- Hex:6 HexNAc:3 NeuAc:1 (avg mass : 1891.7126 )
- Hex:6 HexNAc:3 dHex:1 (avg mass : 1746.5977 )
- Hex:6 HexNAc:3 dHex:1 NeuAc:1 (avg mass : 2037.8556 )
- Hex:6 HexNAc:3 dHex:2 (avg mass : 1892.7407 )
- Hex:6 HexNAc:3 dHex:3 (avg mass : 2038.8837 )
- Hex:6 HexNAc:4 dHex:2 (avg mass : 2095.9357 )
- Hex:7 HexNAc:2 (avg mass : 1559.4021 )
- Hex:7 HexNAc:4 dHex:1 (avg mass : 2111.9351 )
- Hex:8 HexNAc:2 (avg mass : 1721.5445 )
- Hex:9 HexNAc:2 (avg mass : 1883.6869 )
- Hex:12 HexNAc:2 (avg mass : 2370.1141 )
Composition
- Cancer, breast (DOID:1612)
Disease
- Integrin alpha-V / Homo sapiens
Reported glycosite
- ANTTQPGIVEGGQVIK (16aa)
- ARPVITVNAGLEVYPSILNQDNK (23aa)
- TAADTTGIQPIINQFTPANISR (22aa)
- ENQNHSYSIK (10aa)
Mass spectrometry observed peptide
-
- Hex:5 HexNAc:2 / N-Linked (avg mass : 1235.1173)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Integrin alpha-V / Homo sapiens
- ANTTQPGIVEGGQVIK (16aa)
- ARPVITVNAGLEVYPSILNQDNK (23aa)
- ENQNHSYSIK (10aa)
-
- Hex:5 HexNAc:2 dHex:1 / N-Linked (avg mass : 1381.2603)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Integrin alpha-V / Homo sapiens
- ENQNHSYSIK (10aa)
-
- Hex:6 HexNAc:2 / N-Linked (avg mass : 1397.2597)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Integrin alpha-V / Homo sapiens
- ENQNHSYSIK (10aa)
-
- Hex:5 HexNAc:3 / N-Linked (avg mass : 1438.3123)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Integrin alpha-V / Homo sapiens
- ANTTQPGIVEGGQVIK (16aa)
-
- Hex:7 HexNAc:2 / N-Linked (avg mass : 1559.4021)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Integrin alpha-V / Homo sapiens
- TAADTTGIQPIINQFTPANISR (22aa)
- ENQNHSYSIK (10aa)
-
- Hex:5 HexNAc:3 dHex:1 / N-Linked (avg mass : 1584.4553)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Integrin alpha-V / Homo sapiens
- ANTTQPGIVEGGQVIK (16aa)
-
- Hex:6 HexNAc:3 / N-Linked (avg mass : 1600.4547)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Integrin alpha-V / Homo sapiens
- ANTTQPGIVEGGQVIK (16aa)
- ENQNHSYSIK (10aa)
-
- Hex:4 HexNAc:3 dHex:3 / N-Linked (avg mass : 1714.5989)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Integrin alpha-V / Homo sapiens
- ANTTQPGIVEGGQVIK (16aa)
- TAADTTGIQPIINQFTPANISR (22aa)
-
- Hex:8 HexNAc:2 / N-Linked (avg mass : 1721.5445)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Integrin alpha-V / Homo sapiens
- ANTTQPGIVEGGQVIK (16aa)
- TAADTTGIQPIINQFTPANISR (22aa)
- ENQNHSYSIK (10aa)
-
- Hex:5 HexNAc:3 dHex:2 / N-Linked (avg mass : 1730.5983)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Integrin alpha-V / Homo sapiens
- ANTTQPGIVEGGQVIK (16aa)
-
- Hex:6 HexNAc:3 dHex:1 / N-Linked (avg mass : 1746.5977)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Integrin alpha-V / Homo sapiens
- ANTTQPGIVEGGQVIK (16aa)
-
- Hex:5 HexNAc:4 dHex:1 / N-Linked (avg mass : 1787.6503)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Integrin alpha-V / Homo sapiens
- ANTTQPGIVEGGQVIK (16aa)
-
- Hex:5 HexNAc:3 dHex:3 / N-Linked (avg mass : 1876.7413)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Integrin alpha-V / Homo sapiens
- ANTTQPGIVEGGQVIK (16aa)
-
- Hex:9 HexNAc:2 / N-Linked (avg mass : 1883.6869)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Integrin alpha-V / Homo sapiens
- TAADTTGIQPIINQFTPANISR (22aa)
-
- Hex:4 HexNAc:6 / N-Linked (avg mass : 1885.7549)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Integrin alpha-V / Homo sapiens
- TAADTTGIQPIINQFTPANISR (22aa)
-
- Hex:6 HexNAc:3 NeuAc:1 / N-Linked (avg mass : 1891.7126)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Integrin alpha-V / Homo sapiens
- ENQNHSYSIK (10aa)
-
- Hex:6 HexNAc:3 dHex:2 / N-Linked (avg mass : 1892.7407)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Integrin alpha-V / Homo sapiens
- ANTTQPGIVEGGQVIK (16aa)
- ENQNHSYSIK (10aa)
-
- Hex:3 HexNAc:4 NeuAc:2 / N-Linked (avg mass : 1899.7383)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Integrin alpha-V / Homo sapiens
- TAADTTGIQPIINQFTPANISR (22aa)
-
- Hex:6 HexNAc:3 dHex:1 NeuAc:1 / N-Linked (avg mass : 2037.8556)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Integrin alpha-V / Homo sapiens
- ENQNHSYSIK (10aa)
-
- Hex:6 HexNAc:3 dHex:3 / N-Linked (avg mass : 2038.8837)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Integrin alpha-V / Homo sapiens
- ANTTQPGIVEGGQVIK (16aa)
-
- Hex:4 HexNAc:4 dHex:2 NeuAc:1 / N-Linked (avg mass : 2062.9088)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Integrin alpha-V / Homo sapiens
- TAADTTGIQPIINQFTPANISR (22aa)
-
- Hex:5 HexNAc:4 dHex:3 / N-Linked (avg mass : 2079.9363)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Integrin alpha-V / Homo sapiens
- ANTTQPGIVEGGQVIK (16aa)
-
- Hex:6 HexNAc:4 dHex:2 / N-Linked (avg mass : 2095.9357)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Integrin alpha-V / Homo sapiens
- ANTTQPGIVEGGQVIK (16aa)
-
- Hex:7 HexNAc:4 dHex:1 / N-Linked (avg mass : 2111.9351)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Integrin alpha-V / Homo sapiens
- ANTTQPGIVEGGQVIK (16aa)
-
- Hex:5 HexNAc:4 NeuAc:2 / N-Linked (avg mass : 2224.0231)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Integrin alpha-V / Homo sapiens
- ANTTQPGIVEGGQVIK (16aa)
-
- Hex:5 HexNAc:4 dHex:2 NeuAc:1 / N-Linked (avg mass : 2225.0512)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Integrin alpha-V / Homo sapiens
- ANTTQPGIVEGGQVIK (16aa)
-
- Hex:5 HexNAc:4 dHex:4 / N-Linked (avg mass : 2226.0793)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Integrin alpha-V / Homo sapiens
- ANTTQPGIVEGGQVIK (16aa)
-
- Hex:12 HexNAc:2 / N-Linked (avg mass : 2370.1141)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Integrin alpha-V / Homo sapiens
- ANTTQPGIVEGGQVIK (16aa)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
